- Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
-
Keizman D, Rouvinov K, Sella A, Gottfried , Maimon N, Kim JJ, Eisenberger MA, Sinibaldi , Peer A, Carducci M, Mermershtain W, Leibowitz-amit R, Weitzen R, Berger R
- KMID: 2152286
- Cancer Res Treat.
- 2016 Jan;48(1):281-287.
- doi: 10.4143/crt.2014.289
PURPOSE: Studies suggested the existence of a 'trial effect', in which for a given treatment, participation in a clinical trial is associated with a better outcome. Sunitinib is a standard... -
- CITED
-
- Close
- SHARE
-
- Close
